Skye Bioscience (SKYE) Receivables - Net (2012 - 2014)
Skye Bioscience's Receivables - Net was $35,425 in Q1 2014.
Analysis
Skye Bioscience (SKYE) Receivables - Net (2012 - 2014) Analysis & Trends
At the end of FY2013, Receivables - Net at Skye Bioscience came in at $25,338, up 266.9% from FY2012.
- In earlier years, Receivables - Net was $6,906 in FY2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn |
| 10 | Skye Bioscience | 5.38 Mn | -52.34 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2014 | 35,425.00 |
| Oct 31, 2013 | 25,338.00 |
| Jul 31, 2013 | 28,666.00 |
| Apr 30, 2013 | 32,078.00 |
| Oct 31, 2012 | 6,906.00 |
API Access
Skye Bioscience Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=SKYE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();